23andMe 'committed to engaging' FDA after sales halt
23andMe is working with AOR WCG after the Food and Drug Administration ordered it to stop sales of its genetic testing kits, which had not received proper clearance and approval.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>